zanidatamab and chemotherapy in her2 gastroesophageal cancer
Published 1 year ago • 406 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
2:13
zanidatamab chemo as 1l therapy in her2-expressing gea
-
2:55
zanidatamab: her2-targeting bispecific antibody in her2-expressing gea
-
2:39
first line immunotherapy/chemotherapy in her2- gastric cancer in japan
-
1:04
panthera: pembrolizumab, trastuzumab, and chemotherapy in her2 advanced gastric cancer
-
7:37
zanidatamab for her2-amplified, unresectable, locally advanced or metastatic biliary tract cancer
-
3:12
advances in her2-targeted therapies for gastric cancer
-
0:54
targeted treatment for gastric cancer beyond her2
-
2:24
asco 2024 top 5 zanidatamab phase 2 her2 questions on biliary tract cancer
-
1:43
gasther2: trastuzumab for advanced gastric cancer
-
8:01
innovation: chemotherapy with trastuzumab and pertuzumab in her2 gastric cancer
-
2:15
treatments for her2 esophagogastric cancer
-
28:57
evolution of her2-targeted therapy in gastroesophageal adenocarcinoma
-
1:40
keynote-811: trastuzumab chemotherapy with or without pembrolizumab for her2 g/gej cancer
-
56:48
immunotherapy for gastroesophageal cancer
-
19:01
new agents in gastric cancer
-
28:57
for pharmacists: evolution of her2-targeted therapy in gastroesophageal adenocarcinoma
-
1:18:52
her2-positive gastrointestinal cancers: new evidence and practical guidance with targeted agents
-
3:24
her2 testing in gastroesophageal cancers
-
4:41
destiny-gastric03: trastuzumab deruxtecan in her2-overexpressing gastric cancer